Facebook Theophylline and Aminophylline: The Methylxanthine Bronchodilators for Reversible Airway Obstruction – 4.4% CAGR Driven by COPD and Asthma Prevalence
Logo

Theophylline and Aminophylline: The Methylxanthine Bronchodilators for Reversible Airway Obstruction – 4.4% CAGR Driven by COPD and Asthma Prevalence

クレジット
Avatar
イラストレーター
Theophylline and Aminophylline: The Methylxanthine Bronchodilators for Reversible Airway Obstruction – 4.4% CAGR Driven by COPD and Asthma Prevalence-1
シェア
Ciciの他の作品